A complete index of Blake Vanderhyde's published writing, organized by body of work with links to where each is available.
Blake's writing is offered freely as a public contribution. The works listed below are intended for readers who want to engage substantively with the underlying problems they address: plaintiff legal practice, mass tort injury and access to representation, antimicrobial resistance, and the responsible application of artificial intelligence in regulated professions.
A twenty-seven part investigation into the global antimicrobial resistance crisis, published in 2026. It traces a five-year inquiry into the science, the regulatory pathways, the commercial structures, and the ethical considerations of the crisis.
Published in full on Medium: Antimicrobial Resistance: A 5 Year Investigation by Blake Vanderhyde
An overview of the investigation is available at Antimicrobial Resistance. Portions of the work originally appeared on LinkedIn and at vanderhydeconsulting.com before being published as a consolidated investigation on Medium.
n ongoing series of articles examining the application of artificial intelligence to the practice of law.
The first series is designed to help lawyers develop a practical, informed understanding of artificial intelligence. Rather than embracing the hype or dismissing the technology outright, it provides a balanced framework for evaluating AI's capabilities, limitations, risks, and appropriate uses within legal practice.
A second series will be published with themes that include the structural problem of access to representation for victims of mass injury, the economics of plaintiff legal marketing, the specific ways artificial intelligence can be deployed responsibly in a regulated profession.
The series is published on Vanderhyde Consulting and on LinkedIn.
The context and current scope are detailed at AI for Lawyers.
The organized record of Dr. Eliaz Babaev's body of work in low-frequency ultrasound, including his patents and the surrounding research literature, compiled by Blake Vanderhyde. Blake holds no equity or financial interest in the technology.
Published at Low Frequency Ultrasound.
Blake holds no equity or financial interest in the technology.
Educational and analytical articles addressing the antimicrobial resistance crisis and the low-frequency ultrasound technology operated through Arobella Medical, LLC, including a structured library of supporting science, regulatory considerations, and historical parallels.
Published at Superbug Treatments.
Blake holds no equity or financial interest in the technology.
Additional published writing on legal marketing, plaintiff practice strategy, mass tort litigation, and related topics, primarily on LinkedIn. A selected archive is maintained on the Vanderhyde Consulting and Vanderhyde Law LinkedIn profiles.
All works listed on this page are written by Blake Vanderhyde alone unless otherwise noted. The works are offered for educational and informational purposes. They do not constitute medical advice, legal advice, investment advice, or a solicitation of any kind. Disclaimers specific to each work appear within those works where applicable.
Anyone wishing to quote from, reference, or build on these works is welcome to do so. The antimicrobial resistance investigation in particular is offered freely. The framework is available for any qualified researcher, clinician, regulator, or operator who finds it useful. Inquiries about more substantial republication, translation, or licensing arrangements may be directed through the contact information on the home page.